Humana Inc vs TJX Companies Inc — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while TJX Companies Inc trades at $156.2 (market cap $175.45B). The key difference: TJX Companies Inc is far larger — about 3.8× Humana Inc's market cap, and TJX Companies Inc pays the higher dividend (1.21%). Which is the better fit depends on your goals.
| HUM | TJX | |
|---|---|---|
Market Cap | $46.31B | $175.45B |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $168.41 |
52-Week Low | $163.67 | $132.40 |
Enterprise Value | $53.67B | $184.05B |
Dividend Yield | 0.92% | 1.21% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
TJX trades at $161.36, down 0.42% on the day, with strong technical momentum indicated by bullish moving averages and key support at $160. The company demonstrates robust fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.19 beating expectations of $1.02, and impressive profitability metrics including 61.25% ROE and 9.4% net margin. Revenue growth continues steadily from $48.5B in 2022 to $56.4B in 2025, with positive cash flow trends projected for 2026.
TJX presents a compelling growth story with strong analyst support (88% buy ratings) and a $181.80 consensus price target offering 12.7% upside. The discount retail model shows resilience amid economic uncertainty, though elevated valuation multiples (P/E 31.39) and competitive pressures represent key risks. Upcoming Q2 FY27 earnings on August 19, 2026 will be crucial for validating the growth trajectory.
Trailing returns across standard periods
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →